Regulation of MDM2 E3 Ligase Activity by Phosphorylation after DNA Damage

被引:50
作者
Cheng, Qian [1 ]
Cross, Brittany [1 ]
Li, Baozong [1 ]
Chen, Lihong [1 ]
Li, Zhenyu [1 ]
Chen, Jiandong [1 ]
机构
[1] H Lee Moffitt Canc Ctr & Res Inst, Dept Mol Oncol, Tampa, FL 33612 USA
基金
美国国家卫生研究院;
关键词
UBIQUITIN-PROTEIN LIGASE; RING DOMAIN; EMBRYONIC LETHALITY; MDM2-DEFICIENT MICE; NUCLEAR EXPORT; ACIDIC DOMAIN; P53; STABILITY; DEGRADATION; BINDING; SITE;
D O I
10.1128/MCB.05553-11
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
MDM2 is a major regulator of p53 by acting as a ubiquitin E3 ligase. The central acidic domain and C-terminal RING domain of MDM2 are both indispensable for ubiquitination of p53. Our previous study suggested that ATM phosphorylation of MDM2 near the C terminus inhibits RING domain oligomerization, resulting in p53 stabilization after DNA damage. We present here evidence that these modifications allosterically regulate the functions of both acidic domain and RING domain of MDM2. Using chemical cross-linking, we show that the MDM2 RING domain forms oligomers including dimer and higher-order complexes in vivo. RING domain dimerization efficiency is negatively regulated by upstream sequence. ATM-mediated phosphorylation of the upstream sequence further inhibits RING dimerization. Forced oligomerization of MDM2 partially overcomes the inhibitory effect of phosphorylation and stimulates p53 ubiquitination. Furthermore, the ability of MDM2 acidic domain to bind p53 core domain and induce p53 misfolding are also suppressed by the same C-terminal ATM sites after DNA damage. These results suggest that the acidic domain and RING domain of MDM2 are both allosterically coupled to the intervening ATM sites, which enables the same modification to regulate multiple MDM2 functions critical for p53 ubiquitination.
引用
收藏
页码:4951 / 4963
页数:13
相关论文
共 50 条
  • [31] Mayo LD, 1997, CANCER RES, V57, P5013
  • [32] Critical role for a central part of Mdm2 in the ubiquitylation of p53
    Meulmeester, E
    Frenk, R
    Stad, R
    de Graaf, P
    Marine, JC
    Vousden, KH
    Jochemsen, AG
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 2003, 23 (14) : 4929 - 4938
  • [33] Structure-based Design of High Affinity Peptides Inhibiting the Interaction of p53 with MDM2 and MDMX
    Phan, Jason
    Li, Zhenyu
    Kasprzak, Agnieszka
    Li, Baozong
    Sebti, Said
    Guida, Wayne
    Schoenbrunn, Ernst
    Chen, Jiandong
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2010, 285 (03) : 2174 - 2183
  • [34] The Mdm2 RING domain C-terminus is required for supramolecular assembly and ubiquitin ligase activity
    Poyurovsky, Masha V.
    Priest, Christina
    Kentsis, Alex
    Borden, Katherine L. B.
    Pan, Zhen-Qiang
    Pavletich, Nikola
    Prives, Carol
    [J]. EMBO JOURNAL, 2007, 26 (01) : 90 - 101
  • [35] Prives C, 1999, J PATHOL, V187, P112
  • [36] MDM2 binding induces a conformational change in p53 that is opposed by heat-shock protein 90 and precedes p53 proteasomal degradation
    Sasaki, Mark
    Nie, Linghu
    Maki, Carl G.
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2007, 282 (19) : 14626 - 14634
  • [37] Divorcing ARF and p53: an unsettled case
    Sherr, Charles J.
    [J]. NATURE REVIEWS CANCER, 2006, 6 (09) : 663 - 673
  • [38] DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2
    Shieh, SY
    Ikeda, M
    Taya, Y
    Prives, C
    [J]. CELL, 1997, 91 (03) : 325 - 334
  • [39] Shieh SY, 2000, GENE DEV, V14, P289
  • [40] Functional role of Mdm2 phosphorylation by ATR in attenuation of p53 nuclear export
    Shinozaki, T
    Nota, A
    Taya, Y
    Okamoto, K
    [J]. ONCOGENE, 2003, 22 (55) : 8870 - 8880